Moberg Pharma AB (publ) (STO:MOB)

Moberg Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	268.9	293.29	60.56	125.55	102.66	19.29
Cash & Short-Term Investments	268.9	293.29	60.56	125.55	102.66	19.29
Cash Growth	596.06%	384.33%	-51.77%	22.30%	432.28%	-46.83%
Accounts Receivable	6.78	0.17	-	0.38	0.47	-
Other Receivables	-	0.64	0.79	1.06	0.66	2.16
Receivables	6.78	0.8	0.79	1.44	1.14	2.16
Inventory	5.92	4.3	7.12	-	-	-
Prepaid Expenses	-	1.58	0.9	0.72	0.75	0.85
Other Current Assets	-	0.14	0.14	0.06	0.12	144.52
Total Current Assets	281.6	300.11	69.49	127.76	104.66	166.81
Property, Plant & Equipment	4.02	4.42	4.94	5.98	4.52	7.1
Long-Term Deferred Tax Assets	96.2	95.78	28.08	22.58	14.67	10.93
Long-Term Deferred Charges	321.06	305.77	532.22	408.1	327.04	295.73
Total Assets	702.87	706.09	634.73	564.42	450.89	480.58
Accounts Payable	-	4.16	6.77	17.11	5.31	2.95
Accrued Expenses	-	10.67	12.5	7.56	7.45	8.73
Current Portion of Leases	1.62	1.6	1.27	2.12	2.7	2.64
Other Current Liabilities	13.65	0.29	-	-	0.09	65.87
Total Current Liabilities	15.26	16.72	20.54	26.79	15.54	80.18
Long-Term Leases	2.14	2.55	3.47	3.99	1.24	4.75
Other Long-Term Liabilities	-	-	-	0.07	0.07	0.07
Total Liabilities	17.4	19.27	24.01	30.84	16.84	85
Common Stock	46.69	46.69	27.96	9.83	4.41	2.09
Additional Paid-In Capital	1,235	1,234	921.3	841.2	731.38	693.28
Retained Earnings	-596.41	-593.64	-338.53	-317.44	-301.73	-309.22
Comprehensive Income & Other	-	-	-	-	-	1.73
Total Common Equity	685.48	686.82	610.73	533.58	434.05	387.87
Minority Interest	-	-	-	-	-	7.71
Shareholders' Equity	685.48	686.82	610.73	533.58	434.05	395.58
Total Liabilities & Equity	702.87	706.09	634.73	564.42	450.89	480.58
Total Debt	3.75	4.14	4.74	6.11	3.93	7.4
Net Cash (Debt)	265.14	289.15	55.82	119.45	98.72	11.89
Net Cash Growth	675.14%	418.02%	-53.27%	20.99%	730.24%	-47.89%
Net Cash Per Share	6.23	7.64	3.52	15.74	22.94	6.28
Filing Date Shares Outstanding	46.69	46.69	27.96	9.83	4.4	1.99
Total Common Shares Outstanding	46.69	46.69	27.96	9.83	4.4	1.99
Working Capital	266.34	283.39	48.95	100.97	89.12	86.63
Book Value Per Share	14.68	14.71	21.84	54.30	98.54	195.26
Tangible Book Value	685.48	686.82	610.73	533.58	434.05	387.87
Tangible Book Value Per Share	14.68	14.71	21.84	54.30	98.54	195.26

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.